Literature DB >> 23422205

New medical reform and the sustainable development of the pharmaceutical industry in China.

Yi Zhou1, Lan-juan Li.   

Abstract

Mesh：

Year:  2013        PMID： 23422205

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  3 in total

1.  The Impact of Medical and Health Fiscal Expenditures on Pharmaceutical Industry Stock Index in China.

Authors:  Chiwei Su; Yiru Liu; Chang Liu; Ran Tao
Journal:  Int J Environ Res Public Health       Date:  2022-09-17       Impact factor: 4.614

2.  Ecopharmacovigilance: Current state, challenges, and opportunities in China.

Authors:  Jun Wang; Xiamin Hu
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

3.  Knowledge, Attitudes, and Social Responsiveness Toward Corona Virus Disease 2019 (COVID-19) Among Chinese Medical Students-Thoughts on Medical Education.

Authors:  Haojun Yang; Yue Zheng; Fang Yu; Bohao Cheng; Ziqing Zhu; Sheng Liao; Yu Chen; Jianzhen Wu; Fang Wang
Journal:  Front Med (Lausanne)       Date:  2021-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.